Published in J Immunol on December 01, 1982
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A (1989) 5.97
Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene. EMBO J (1987) 3.64
Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med (1989) 2.81
Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med (1986) 2.62
Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci U S A (1989) 2.56
Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein. Biochem J (1984) 2.47
Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med (1989) 2.32
How (and why) the immune system makes us sleep. Nat Rev Neurosci (2009) 2.22
Mechanisms of fever induced by recombinant human interferon. J Clin Invest (1984) 1.81
The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis. Acta Neuropathol (1986) 1.77
Bacteroides gingivalis fimbriae stimulate production of thymocyte-activating factor by human gingival fibroblasts. Infect Immun (1988) 1.69
Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (1987) 1.68
Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med (1991) 1.55
Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ Health Perspect (2003) 1.47
Pathogenesis and pathophysiology of bacterial meningitis. Clin Microbiol Rev (1993) 1.45
Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J Clin Invest (1997) 1.43
Optimization of multiplexed bead-based cytokine immunoassays for rat serum and brain tissue. J Neurosci Methods (2004) 1.41
Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J Leukoc Biol (2002) 1.38
Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins. Nucleic Acids Res (1990) 1.32
Theiler's virus replication in brain macrophages cultured in vitro. J Virol (1992) 1.30
Interleukin 1 amplifies receptor-mediated activation of phospholipase A2 in 3T3 fibroblasts. Proc Natl Acad Sci U S A (1988) 1.29
Intrathecal application of interferon gamma. Progressive appearance of MHC antigens within the rat nervous system. Am J Pathol (1990) 1.27
Human interleukin 1 beta is not secreted from hamster fibroblasts when expressed constitutively from a transfected cDNA. J Cell Biol (1988) 1.25
Antigen presentation in brain: MHC induction on brain endothelium and astrocytes compared. Immunology (1987) 1.24
IL-1 and TNF-alpha induction of IL-8 and monocyte chemotactic and activating factor (MCAF) mRNA expression in a human astrocytoma cell line. Immunology (1991) 1.23
Cell cycle-dependent interleukin 1 gene expression by cultured glomerular mesangial cells. J Clin Invest (1988) 1.20
Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF. Br J Pharmacol (2010) 1.16
Chronic-pain-associated astrocytic reaction in the spinal cord dorsal horn of human immunodeficiency virus-infected patients. J Neurosci (2012) 1.15
Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation. Acta Neuropathol (1990) 1.14
Regional and cellular codistribution of interleukin 1 beta and nerve growth factor mRNA in the adult rat brain: possible relationship to the regulation of nerve growth factor synthesis. J Cell Biol (1990) 1.13
Stimulating effect of MDP and its adjuvant-active analogues on guinea pig fibroblasts for the production of thymocyte-activating factor. J Exp Med (1983) 1.11
Science review: The brain in sepsis--culprit and victim. Crit Care (2004) 1.11
Differential tumor necrosis factor alpha expression by astrocytes from experimental allergic encephalomyelitis-susceptible and -resistant rat strains. J Exp Med (1991) 1.10
Proinflammatory cytokine, chemokine, and cellular adhesion molecule expression during the acute phase of experimental brain abscess development. Am J Pathol (2000) 1.06
Heightened expression of tumor necrosis factor alpha, interleukin 1 alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc Natl Acad Sci U S A (1996) 1.03
Cerebrospinal fluid concentrations of interleukin-1 beta, tumour necrosis factor-alpha, and interferon gamma in bacterial meningitis. Arch Dis Child (1994) 1.02
Antigen presentation in brain: brain endothelial cells are poor stimulators of T-cell proliferation. Immunology (1989) 1.00
Norepinephrine inhibits gamma-interferon-induced major histocompatibility class II (Ia) antigen expression on cultured astrocytes via beta-2-adrenergic signal transduction mechanisms. Proc Natl Acad Sci U S A (1988) 1.00
Functional anatomy of the thymic microenvironment. J Anat (1991) 1.00
All in the head: obstacles for immune rejection of brain tumours. Immunology (2002) 0.99
Multiple control of fever production in the central nervous system of rabbits. J Physiol (1988) 0.99
Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions. Immunology (1992) 0.95
Interleukin-1 production by mononuclear cells from patients with scleroderma. Clin Exp Immunol (1985) 0.95
Neuromodulative actions of cytokines. Yale J Biol Med (1990) 0.95
Acute stress modulates the histamine content of mast cells in the gastrointestinal tract through interleukin-1 and corticotropin-releasing factor release in rats. J Physiol (2003) 0.94
Possible involvement of prostaglandins in psychological stress-induced responses in rats. J Physiol (1991) 0.94
Is prostaglandin E2 involved in the pathogenesis of fever? Effects of interleukin-1 on the release of prostaglandins. Yale J Biol Med (1986) 0.92
Separate mechanisms inside and outside the blood-brain barrier inducing metabolic changes in febrile rabbits. J Physiol (1987) 0.92
Roles of interferon produced in physiological conditions. A speculative review. Immunology (1988) 0.91
Studies of an interleukin 1 inhibitor: characterization and clinical significance. Clin Exp Immunol (1986) 0.91
Somnogenic cytokines and models concerning their effects on sleep. Yale J Biol Med (1990) 0.89
Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease. Clin Exp Immunol (1986) 0.89
Age-related changes in brain support cells: Implications for stroke severity. Neurochem Int (2013) 0.89
Flare-up reaction of streptococcal cell wall induced arthritis in Lewis and F344 rats: the role of T lymphocytes. Clin Exp Immunol (1990) 0.89
Expression of interferon-gamma receptors on murine oligodendrocytes and its regulation by cytokines and mitogens. Immunology (1995) 0.88
Interleukin 2 mediates the inhibition of oligodendrocyte progenitor cell proliferation in vitro. Proc Natl Acad Sci U S A (1986) 0.88
Pathophysiologic effect of interleukin-1b in the rabbit retina. Am J Pathol (1990) 0.88
Production of a lymphocyte proliferation potentiating factor by purified polymorphonuclear leucocytes from mice and rabbits. Immunology (1984) 0.86
Cyclooxygenase-1 and -2 are required for production of infectious pseudorabies virus. J Virol (2004) 0.86
In situ inactivation of infiltrating T cells in the central nervous system with autoimmune encephalomyelitis. The role of astrocytes. Immunology (1993) 0.86
Feline immunodeficiency virus decreases cell-cell communication and mitochondrial membrane potential. J Virol (1994) 0.85
Somnogenic activity of O-acetylated and dimeric muramyl peptides. Infect Immun (1989) 0.85
Brain regions involved in the development of acute phase responses accompanying fever in rabbits. J Physiol (1989) 0.85
Theiler's murine encephalomyelitis virus induces tumour necrosis factor-alpha in murine astrocyte cell cultures. Immunology (1993) 0.84
In silico experimentation of glioma microenvironment development and anti-tumor therapy. PLoS Comput Biol (2012) 0.84
Age-related severity of focal ischemia in female rats is associated with impaired astrocyte function. Neurobiol Aging (2011) 0.84
Immunotherapy for malignant gliomas: emphasis on strategies of active specific immunotherapy using autologous dendritic cells. Childs Nerv Syst (2004) 0.83
Functional and structural differences in febrile mechanism between rabbits and rats. J Physiol (1990) 0.83
Microglia in invertebrate ganglia. Proc Natl Acad Sci U S A (1994) 0.82
IL-1, IL-2 and IFN-gamma production by Theiler's virus-induced encephalomyelitic SJL/J mice. Immunology (1991) 0.82
Interleukin-1 beta production in the rabbit brain during endotoxin-induced fever. J Physiol (1994) 0.81
Brain microvascular smooth muscle and endothelial cells produce granulocyte macrophage colony-stimulating factor and support colony formation of granulocyte-macrophage-like cells. Am J Pathol (1992) 0.81
Autonomic regulation of neuroimmunological responses: implications for multiple sclerosis. J Clin Immunol (2001) 0.79
Purification and characterization of a human T-lymphocyte-derived glial growth-promoting factor. Proc Natl Acad Sci U S A (1985) 0.79
Autoimmune disease and the nervous system. Biochemical, molecular, and clinical update. West J Med (1992) 0.79
Interleukin 1 expression is inducible by nerve growth factor in PC12 pheochromocytoma cells. Proc Natl Acad Sci U S A (1991) 0.78
Neural responses to antigenic challenges and immunomodulatory factors. Yale J Biol Med (1990) 0.78
Immunotherapy of malignant gliomas using autologous and allogeneic tissue cells. Anticancer Agents Med Chem (2010) 0.78
Demonstration of the presence of an interleukin-1 receptor on the surface of murine astrocytes and its regulation by cytokines and Theiler's virus. Immunology (1994) 0.78
Production, regulation and role of nitric oxide in glial cells. Mediators Inflamm (1998) 0.77
Cytokine gene expression within the central nervous system. Cell Mol Neurobiol (1998) 0.77
Cerebrospinal fluid interleukin 1 like activity during chronic relapsing experimental allergic encephalomyelitis. Clin Exp Immunol (1987) 0.77
Astrocytes from acyclic female rats exhibit lowered capacity for neuronal differentiation. Aging Cell (2008) 0.77
Inhibition of the induction of the inducible nitric oxide synthase in murine brain microglial cells by sodium salicylate. Immunology (1998) 0.76
Production of prostaglandins and thromboxane by isolated cells from intracranial tumours. J Neurol Neurosurg Psychiatry (1984) 0.76
Stimulation of human fetal astrocyte proliferation by bacterial lipopolysaccharides and lipid A. Acta Neuropathol (1991) 0.75
Distribution of endogenous tumour necrosis factor alpha in gliomas. J Clin Pathol (1997) 0.75
Room-temperature ultraviolet nanowire nanolasers. Science (2001) 9.79
Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science (1996) 6.02
Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature (1994) 5.70
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A (1996) 3.79
Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med (1998) 3.72
Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature (1984) 3.71
Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science (1996) 3.35
Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol (1988) 2.58
Structure of erythrocruorin in different ligand states refined at 1.4 A resolution. J Mol Biol (1979) 2.51
Cloning and expression of a receptor for an insecticidal toxin of Bacillus thuringiensis. J Biol Chem (1995) 2.49
Evidence for lysosomal enzyme recognition by human fibroblasts via a phosphorylated carbohydrate moiety. Biochem J (1978) 2.46
IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur J Immunol (1998) 2.44
Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur J Immunol (1987) 2.41
Production and detection of cold antihydrogen atoms. Nature (2002) 2.31
Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int (1982) 2.24
Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family. EMBO J (1987) 2.23
On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur J Immunol (1989) 2.20
Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J Biol Chem (1995) 2.17
Forest ecosystem development in post-mining landscapes: a case study of the Lusatian lignite district. Naturwissenschaften (2001) 2.17
The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat Med (1995) 2.08
Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients. J Exp Med (1988) 2.02
Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00
Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L). Proc Natl Acad Sci U S A (1999) 1.99
Programmed cell death (apoptosis) in human monocytes infected by influenza A virus. Immunobiology (1994) 1.98
A model of homelessness among male veterans of the Vietnam War generation. Am J Psychiatry (1994) 1.97
Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes (2001) 1.95
Old galaxies in the young Universe. Nature (2004) 1.90
CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood (1997) 1.89
Astrocytes as antigen-presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J Immunol (1985) 1.88
Correlation between sites of limited proteolysis and segmental mobility in thermolysin. Biochemistry (1986) 1.80
Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med (1988) 1.79
Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2. J Immunol (1989) 1.79
Cathepsin K--a marker of macrophage differentiation? J Pathol (2001) 1.77
Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction? J Immunol (1984) 1.71
Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol (1984) 1.68
Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (1987) 1.68
An alternative hypothesis of cellular transport of lysosomal enzymes in fibroblasts. Effect of inhibitors of lysosomal enzyme endocytosis on intra- and extra-cellular lysosomal enzyme activities. Biochem J (1978) 1.67
Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production. J Immunol (1983) 1.66
Outcome of intensive inpatient treatment for combat-related posttraumatic stress disorder. Am J Psychiatry (1996) 1.65
Growth rate of 147 mammary carcinomas. Cancer (1980) 1.62
Theta-frequency bursting and resonance in cerebellar granule cells: experimental evidence and modeling of a slow k+-dependent mechanism. J Neurosci (2001) 1.62
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib. Eur J Cancer (2009) 1.62
Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med (1997) 1.61
Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid. J Neuroimmunol (1989) 1.59
T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta. EMBO J (1987) 1.59
Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells. Am J Respir Cell Mol Biol (1999) 1.58
CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res (1992) 1.57
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial. Br J Cancer (2009) 1.54
Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-gamma inducible protein 10. J Neuroimmunol (1999) 1.53
Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha. J Immunol (1988) 1.53
Alcohol consumption and risk of Hodgkin's lymphoma and multiple myeloma: a multicentre case-control study. Ann Oncol (2006) 1.52
Dissociation and posttraumatic stress disorder in Vietnam combat veterans. Am J Psychiatry (1992) 1.52
The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain. Brain Res Brain Res Rev (1995) 1.51
Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clin Immunol Immunopathol (1992) 1.51
Kinetics of the transformation of Gram-negative rods to spheroplasts and ghosts by serum. J Immunol (1966) 1.51
Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response. J Leukoc Biol (1997) 1.51
Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res (1992) 1.51
Modification of the single tryptophan residue of staphylococcal nuclease by a new mild oxidizing agent. J Biol Chem (1970) 1.51
Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia. J Exp Med (1990) 1.48
Pharmacokinetics of technetium-99m-MAG3 in humans. J Nucl Med (1990) 1.48
TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain (2000) 1.47
Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia. J Immunol (1992) 1.47
Dynamics of drug regimen compliance--its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol (1990) 1.47
Idiopathic renal haematuria in a dog. Vet Rec (1994) 1.46
Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest (1994) 1.45
A new polymorph of N-phenyl-phthalimide. Acta Crystallogr Sect E Struct Rep Online (2009) 1.43
Sulfenyl halides as modifying reagents for polypeptides and proteins. I. Modification of tryptophan residues. Biochemistry (1968) 1.41
Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression. J Exp Med (2001) 1.40
Chemokines and chemotaxis of leukocytes in infectious meningitis. J Neuroimmunol (1998) 1.40
Seasonality in clinical onset of type 1 diabetes in belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence. Diabetologia (2004) 1.40
Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. J Exp Med (1988) 1.40
Latitudinal population differentiation in two species of Solidago (Asteraceae) introduced into Europe. Am J Bot (1998) 1.40
Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release. J Immunol (1991) 1.39
[Prioritizing in hospital departments]. Tidsskr Nor Laegeforen (1993) 1.39
Chemicals and drugs as triggers of food-associated disorder. Ann Allergy (1988) 1.39
Role of macrophage cytokines in influenza A virus infections. Immunobiology (1993) 1.39
Images in cardiovascular medicine. Idiopathic hypereosinophilic vasculitis. Circulation (1995) 1.39
Concentrations of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidney. J Cancer Res Clin Oncol (1997) 1.38
A galaxy rapidly forming stars 700 million years after the Big Bang at redshift 7.51. Nature (2013) 1.37
1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci U S A (1986) 1.37
Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J Clin Invest (2001) 1.36
Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor-associated glycine binding site. Mol Pharmacol (1989) 1.36
Tumor necrosis factor-alpha production of influenza A virus-infected macrophages and potentiating effect of lipopolysaccharides. J Immunol (1990) 1.36
Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. J Cell Sci (1999) 1.35
Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J Clin Invest (1995) 1.35
Murine brain macrophages induced NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett (1991) 1.35
Interleukin 1 and the glomerular mesangium. I. Purification and characterization of a mesangial cell-derived autogrowth factor. J Immunol (1986) 1.34
Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur J Immunol (1998) 1.34
Induction of oral tolerance to cellular immune responses in the absence of Peyer's patches. Eur J Immunol (2001) 1.33
Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. J Exp Med (2001) 1.32
Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins. Nucleic Acids Res (1990) 1.32
Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1. Eur J Immunol (1997) 1.31
Chemokines in the cerebrospinal fluid of patients with meningitis. Clin Immunol Immunopathol (1996) 1.31
Primary structure of the uracil transport protein of Saccharomyces cerevisiae. Eur J Biochem (1988) 1.31
Activation of glomerular mesangial cells by the terminal membrane attack complex of complement. J Immunol (1987) 1.30
Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages. J Leukoc Biol (2001) 1.30